Skip to main content
Clinical Trials/NCT01095692
NCT01095692TerminatedNot Applicable

Evaluating the Necessity of TOT Implantation in Women With Pelvic Organ Prolapse and Occult Stress Urinary Incontinence

Assistance Publique - Hôpitaux de Paris2 sites in 1 country21 target enrollmentStarted: July 22, 2010Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Terminated
Enrollment
21
Locations
2
Primary Endpoint
To compare the postoperative prevalence of stress incontinence in patients with or without TOT implant during a pelvic organ prolapse surgery

Study Overview

Brief Summary

Nowadays the clinical significance of an occult stress urinary incontinence and its optimal treatment is not known.Regarding treatment, there are 2 main approaches : either the systematic preventive treatment of the occult stress urinary incontinence by means of a tension free vaginal tape (TOT) together with the treatment of prolapse or the treatment of prolapse in the first place and treatment of stress incontinence in a second time when and if it appears.This study is expected to provide objective evidence concerning the efficacy and security of TOT implantation for the prevention treatment of occult stress urinary incontinence in women with pelvic organ prolapse and occult urinary incontinence.The perspective is to improve the management of these patients by providing evidence based recommendation for their treatment.

Detailed Description

The study population consists of women with pelvic organ prolapse and occult stress urinary incontinence. They are randomised within two groups : one group with pelvic organ prolapse surgery alone and one group with implantation of TOT together with prolapse surgery for prevention of stress urinary incontinence.TOT implantation is performed as described previously, while the pelvic organ prolapse surgery could either be of abdominal (open or laparoscopic) or vaginal approach. Eighty eight (88) patients will be enrolled at 3 sites centers.

This study is a prospective, multicenter, randomised, active-control arm trial. The study population consists of women with pelvic organ prolapse and occult stress urinary incontinence. They are randomised within two groups : one group with pelvic organ prolapse surgery alone and one group with implantation of TOT together with prolapse surgery for prevention of stress urinary incontinence.TOT implantation is performed as described previously, while the pelvic organ prolapse surgery could either be of abdominal (open or laparoscopic) or vaginal approach. Eighty eight (88) patients will be enrolled at 3 sites centers.

Visit I (J-2 months +/- 1 month) :

During this visit the following will be performed :

  • Collection of general medical, obstetric and surgical history of the patients
  • Collection of incontinence, prolapse and sexual history with the following questionnaires :

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Female patients, at least 18 years of age
  • Having a pelvic organ prolapse and occult stress urinary incontinence
  • Patient non opposed to the exploitation of data in research
  • Agree to comply with all protocol-specified procedures, including protocol mandated follow up visits

Exclusion Criteria

  • Symptoms of stress urinary incontinence preoperatively
  • Patients not having social security
  • Pregnancy or lactation

Arms & Interventions

only surgery

Active Comparator

Intervention: Pelvic Organ Prolapse intervention (Procedure)

surgery + TOT

Experimental

Intervention: Pelvic Organ Prolapse and Suburethral TOT implantation (Procedure)

Outcomes

Primary Outcomes

To compare the postoperative prevalence of stress incontinence in patients with or without TOT implant during a pelvic organ prolapse surgery

Time Frame: 6 month

Secondary Outcomes

  • To compare the severity of new onset overactive bladder between the two groups(6 month)
  • To compare the prevalence of postoperative dyspareunia at 6 months between the two groups(6 month)
  • To compare the prevalence of postoperative urinary retention between the two groups(6 month)
  • To compare the severity of postoperative dyspareunia at 6 months between the two groups(6 month)
  • To compare the prevalence of dyschesia and constipation at 6 months between the two groups(6 month)
  • To compare the prevalence of new onset overactive bladder postoperatively between the two groups(6 month)
  • To compare pre- and postoperative urodynamic test of patients when they are incontinent at 6 months(6 month)
  • To compare the severity of postoperative stress urinary incontinence between the two groups(6 month)
  • To compare the postoperative Patient Global Impression of Improvement and degree of satisfaction at 6 months between the 2 groups(6 month)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials